Dr. Ekta Khurana, an associate professor of physiology and biophysics at Weill Cornell Medicine, has received a 3-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become...
Read more
The following article first appeared in the WCM Newsroom on May 29, 2020. Enzalutamide Prolongs Lives of Patients with Nonmetastatic Castration-Resistant Prostate Cancer 3D illustration of prostate cancer cells. Image credit: Shutterstock A drug...
Read more
New Target Identified for Aggressive Form of Prostate Cancer A study by the Englander Institute for Precision Medicine members including first author Loredana Puca, Ph.D., a postdoctoral fellow in the laboratory of Himisha Beltran, M.D....
Read more
Cornell Collaborations “I was able to find the missing pieces to my project and the expertise that I needed.” Collaborations between the Englander Institute for Precision Medicine (EIPM), Cornell University in Ithaca, and Cornell Tech are...
Read more
We’re thrilled to welcome Dolores J. Lamb, Ph.D. to Weill Cornell and the Englander Institute for Precision Medicine team. Dr. Lamb, or ‘Dorrie’ to her friends, studies the fields of urology, male infertility, steroid hormone action, prostate...
Read more
Loredana Puca, Ph.D., and a team of scientists from the Beltran Lab and Englander Institute for Precision Medicine at Weill Cornell Medicine, developed tumor organoids that recapitulate neuroendocrine prostate cancer, a rare and aggressive...
Read more